Endometriosis diagnostics: NHS trial templates + new blood‑test validation
Key Questions
What does the Worcestershire NHS Trust trial offer for endometriosis?
The trial provides a replicable template for earlier and safer endometriosis diagnosis. It supports implementation of non-invasive diagnostics in health systems.
What are the performance metrics of HerAnova's blood test for endometriosis?
In a surgical cohort of 298 patients, it showed ~80% sensitivity, 97.5% NPV, and detected ~61.5% of cases missed by imaging. Diamens menstrual-blood diagnostics serves as a key comparator.
What are the implications of new endometriosis research findings?
Studies link nerve bundle density around lesions to deep dyspareunia and map menstrual cycle changes for broader women's health insights. These support pragmatic trials and reimbursement for non-invasive tests.
Worcestershire Acute Hospitals NHS Trust's trial on earlier/safer endometriosis diagnosis offers a replicable implementation template. New clinical validation: HerAnova's blood test (n=298 surgical cohort) reports ~80% sensitivity, 97.5% NPV and detected ~61.5% of cases missed by imaging; Diamens (menstrual‑blood diagnostics) remains a key comparator. Implication: non‑invasive diagnostics now have comparative clinical data to pursue pragmatic health‑system trials and reimbursement pathways.